4-(4-Aminophenoxy)-N-methylpicolinamide
[4-(4-Aminophenoxy)(2-pyridyl)]-N-methylcarboxamide is an intermediate of Sorafenib, which is a kinase inhibitor drug used for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
Catalog Number | INT284462379 |
Alternative Name(s) | 4-(4-Aminophenoxy)-N-methylpyridine-2-carboxamide 4-(4-Aminophenoxy)-N-methyl-2-pyridinecarboxamide [4-(4-Aminophenoxy)(2-pyridyl)]-N-methylcarboxamide |
Research Area | Intermediates |
Molecular Formula | C13H13N3O2 |
CAS# | 284462-37-9 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)N |
Size | inquiry |
Supplier Page | https://www.protheragen-ing.com/4-4-aminophenoxy-n-methylpicolinamide-item-11143.html |